In late February 2003, the world heard preliminary results of the first large-scale human trial of a vaccine designed to prevent HIV infection. The results for the overall trial cohort were clear and disappointing. The results for a relatively small subset of trial participants are less clear, and they have sparked controversy and require further analysis. This brochure will help you understand what we do and do not know about the experimental vaccine known as AIDSVAX.
Understanding the Results of the AIDSVAX Trial (Spanish)
Multipurpose Prevention Technologies for Reproductive Health
In May 2011, AVAC, USAID and CAMI convened a group of scientists to discuss and recommend strategies for accelerating the development of multipurpose prevention technologies for protection against unintended pregnancy, HIV and other STIs. This report includes the presentations and discussions from the meeting, as well as recommendations for next steps.
Antiretroviral Treatment for Prevention of HIV and Tuberculosis
Despite considerable evidence supporting the use of antiretroviral therapy (ART) for prevention of HIV and TB illness, death and transmission, only 37 percent of the 35 million people living with HIV were receiving it in 2013. This paper examines ongoing and planned global treatment as prevention studies and addresses research questions related to access and implementation.
Ongoing and Planned PrEP Demonstration and Implementation Studies
This is a summary table of ongoing and planned global PrEP evaluation studies.
Global Investment in HIV Cure Research and Development in 2012
In 2013 the International AIDS Society HIV Cure Resource Tracking group joined with the HIV Vaccines and Microbicides Tracking Working Group to estimate global investments in HIV cure research and produce this short report.
Rectal Microbicides Video Facilitator’s Guide
This guide is meant to be used as a preparation tool for people leading community discussions, workshops, or recruitment sessions who will be showing the educational video. Background information on rectal microbicide research and the clinical trial process is included in the guide.
Rectal Microbicides Video Facilitator’s Guide (Spanish)
This guide is meant to be used as a preparation tool for people leading community discussions, workshops, or recruitment sessions who will be showing the educational video in Spanish. Background information on rectal microbicide research and the clinical trial process is included in the guide.
Rectal Microbicides Video Facilitator’s Guide (Thai)
This guide is meant to be used as a preparation tool for people leading community discussions, workshops, or recruitment sessions who will be showing the educational video in Thai. Background information on rectal microbicide research and the clinical trial process is included in the guide.
The GLAM Toolkit: Advocacy to improve access to safe, condom-compatible lubricant in Africa
The GLAM Toolkit: Advocacy to improve access to safe, condom-compatible lubricant in Africa” published by IRMA, amfAR and AVAC, provides background on the status of lubricant (lube) access in Africa and suggests potential strategies for civil society and government partners to secure and distribute sustainable supplies of safe, condom-compatible lube. Global Lube Access Mobilisation (GLAM) is a campaign of IRMA’s Project ARM (Africa for Rectal Microbicides) initiative.
The GLAM Toolkit: Advocacy to improve access to safe, condom-compatible lubricant in Africa (French)
“La boîte à outils GLAM – Plaidoyer pour améliorer l’accès en Afrique à du lubrifiant fiable et adapté au préservatif”, published by IRMA, amfAR and AVAC, provides background on the status of lubricant (lube) access in Africa and suggests potential strategies for civil society and government partners to secure and distribute sustainable supplies of safe, condom-compatible lube. Global Lube Access Mobilisation (GLAM) is a campaign of IRMA’s Project ARM (Africa for Rectal Microbicides) initiative.